Patricia Whitfield1, Amber Parry-Strong2, Emily Walsh2, Mark Weatherall3, Jeremy D Krebs2,3. 1. Centre for Endocrine, Diabetes and Obesity Research, Wellington Regional Hospital, Wellington, New Zealand. patricia.whitfield@ccdhb.org.nz. 2. Centre for Endocrine, Diabetes and Obesity Research, Wellington Regional Hospital, Wellington, New Zealand. 3. Department of Medicine, University of Otago, Wellington, New Zealand.
Abstract
PURPOSE: This randomised controlled trial assessed the acute and long-term effects of daily supplementation of kanuka honey, formulated with cinnamon, chromium and magnesium on glucose metabolism, weight and lipid parameters in individuals with type 2 diabetes. METHODS:Twelve individuals with type 2 diabetes received 53.5 g of a formulated honey and a control (non-formulated) kanuka honey in a random order for 40 days, using cross-over design. Fasting glucose, insulin, HbA1c, lipids and anthropometric measures were measured at baseline and end of treatment. A meal tolerance test was performed at baseline to assess acute metabolic response. RESULTS: There was no statistically significant difference in acute glucose metabolism between treatment groups, as measured by the Matsuda index and AUC for glucose and insulin. After the 40-day intervention with honey, fasting glucose did not differ significantly between the two treatments (95 % CI -2.6 to 0.07). There was no statistically significant change in HbA1c or fasting insulin. There was a statistically significant reduction in total cholesterol by -0.29 mmol/L (95 % CI -0.57 to -0.23), LDL cholesterol by -0.29 mmol/L (95 % CI -0.57 to -0.23) and weight by -2.2 kg (95 % CI -4.2 to -0.1). There was a trend towards increased HDL and reduced systolic blood pressure in the intervention treatment. CONCLUSION: The addition of cinnamon, chromium and magnesium supplementation to kanuka honey was not associated with a significant improvement in glucose metabolism or glycaemic control in individuals with type 2 diabetes. Use of the formulated honey was associated with a reduction in weight and improvements in lipid parameters, and should be investigated further.
RCT Entities:
PURPOSE: This randomised controlled trial assessed the acute and long-term effects of daily supplementation of kanuka honey, formulated with cinnamon, chromium and magnesium on glucose metabolism, weight and lipid parameters in individuals with type 2 diabetes. METHODS: Twelve individuals with type 2 diabetes received 53.5 g of a formulated honey and a control (non-formulated) kanuka honey in a random order for 40 days, using cross-over design. Fasting glucose, insulin, HbA1c, lipids and anthropometric measures were measured at baseline and end of treatment. A meal tolerance test was performed at baseline to assess acute metabolic response. RESULTS: There was no statistically significant difference in acute glucose metabolism between treatment groups, as measured by the Matsuda index and AUC for glucose and insulin. After the 40-day intervention with honey, fasting glucose did not differ significantly between the two treatments (95 % CI -2.6 to 0.07). There was no statistically significant change in HbA1c or fasting insulin. There was a statistically significant reduction in total cholesterol by -0.29 mmol/L (95 % CI -0.57 to -0.23), LDL cholesterol by -0.29 mmol/L (95 % CI -0.57 to -0.23) and weight by -2.2 kg (95 % CI -4.2 to -0.1). There was a trend towards increased HDL and reduced systolic blood pressure in the intervention treatment. CONCLUSION: The addition of cinnamon, chromium and magnesium supplementation to kanuka honey was not associated with a significant improvement in glucose metabolism or glycaemic control in individuals with type 2 diabetes. Use of the formulated honey was associated with a reduction in weight and improvements in lipid parameters, and should be investigated further.
Authors: O O Erejuwa; Erejuwa O Omotayo; Sunil Gurtu; Siti Amrah Sulaiman; Mohd Suhaimi Ab Wahab; K N S Sirajudeen; Md Salzihan Md Salleh Journal: Int J Vitam Nutr Res Date: 2010-01 Impact factor: 1.784
Authors: Mohsen Bahrami; Asal Ataie-Jafari; Saeed Hosseini; Mohammad Hasan Foruzanfar; Mazaher Rahmani; Mohammad Pajouhi Journal: Int J Food Sci Nutr Date: 2009-11 Impact factor: 3.833
Authors: William L Baker; Gabriela Gutierrez-Williams; C Michael White; Jeffrey Kluger; Craig I Coleman Journal: Diabetes Care Date: 2007-10-01 Impact factor: 19.112
Authors: Stephen D Anton; Christopher D Morrison; William T Cefalu; Corby K Martin; Sandra Coulon; Paula Geiselman; Hongmei Han; Christy L White; Donald A Williamson Journal: Diabetes Technol Ther Date: 2008-10 Impact factor: 6.118